SCHEMBL16229889

SCHEMBL16229889

CC[C@@H](C)CF

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL312203 1.00
SCHEMBL7764130 1.00
SCHEMBL19245840 0.83 TSHR (0.30)
SCHEMBL18632260 0.79
SCHEMBL170892 0.79
Isobutane SCHEMBL28141226 0.75
SCHEMBL7654 0.74
SCHEMBL7755370 0.74 TSHR (0.46)
SCHEMBL28142522 0.72 TSHR (0.31)
SCHEMBL24174282 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160207910-A1 Fluorinated 2-arylbenzo heterocyclic compound with high affinity to A beta 946; plaques and containing chiral side chain substituent, and preparation method and usage thereof BEIJING ZHIBO BIO-MEDICAL TECHNOLOGY CO., LTD. (JP) 2016-07-21 US disclosed
EP-2416777-B1 THERAPEUTIC APPLICATIONS IN THE CARDIOVASCULAR FIELD OF QUINAZOLINEDIONE DERIVATIVES SANOFI SA (FR) 2014-11-12 EP disclosed